In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

Summer's rise in COVID-19 cases led to the approval of updated versions of vaccinations targeting recent strains for the 2024 ...

The Ministry of Health has approved Moderna's updated COVID vaccines, which target the new JN1 variant of the virus.

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 ...

The first, an investigational norovirus mRNA vaccine from Moderna (mRNA-1403), safely elicited strong antibody responses in ...

Moderna is trying to find a path to profitability in the wake of disappointing vaccine sales. In September, the company said ...

First ever vaccine for norovirus trialled in the UK which could spell the end for the sickness bug once and for all.

Moderna shares rebound after six days of losses. Analysts mixed on stock with Strong Sell rating but potential for future growth.

With flu season underway and new, developing COVID-19 strains, health professionals continue to stress the importance of receiving an updated vaccine. On Oct. 23, the Centers for Disease Control ...

The Centers for Disease Control recommends staying up to date on COVID-19 vaccinations, especially individuals 65 years and older and those more vulnerable to the virus due to weakened immune systems.